期刊文献+

臭氧与得宝松联合治疗髋关节炎临床观察 被引量:1

臭氧与得宝松联合治疗髋关节炎临床观察
暂未订购
导出
摘要 目的:探讨臭氧与得宝松联合应用与单用得宝松治疗髋关节骨性关节炎的疗效比较。方法:根据随机等量的原则将40例髋关节骨性关节炎患者随机分为臭氧联合得宝松注射组(A组)和得宝松注射组(B组),比较其疗效。结果:臭氧联合得宝松注射组有效率高,且起效快。结论:臭氧和得宝松联合应用治疗髋关节骨性关节炎疗效显著,见效快。 Objective:To compare ozone combined Diprospan and alone Diprospan on treatment of hip osteoarthritis efficacy.Methods:According to the principle of equal random 40 cases of hip osteoarthritis were randomly divided into ozone combined Diprospan injection group (A group),Diprospan injection group (B group) to compare their efficacy.Results:The injection of ozone and Diprospan group Diprospan effective rate of injection group,and the injection of ozone and Diprospan rapid onset group.Conclusion:The effect of ozone combined Diprospan on treatment of hip osteoarthritis is significant and quick.
出处 《中国社区医师(医学专业)》 2011年第12期97-98,共2页
关键词 臭氧 得宝松 髋关节炎 Ozone Diprospan Hip osteoarthritis
  • 相关文献

参考文献4

二级参考文献23

  • 1Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum, 2000, 43: 1905-1915.
  • 2Schnitzer TJ, American College of Rheumatology. Update of ACR guidelines for osteoarthritis: role of the coxibs. J Pain Symptom Manage, 2002, 23(4 Suppl): S24-34.
  • 3Hochberg MC, Ahman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part Ⅱ. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum, 1995, 38:1541-1546.
  • 4Hochberg MC, Ahman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part Ⅰ. Osteoarthritis of the hip. American College of Rheumatology. Arthritis Rheum, 1995, 38: 1535-1540.
  • 5Simon LS, Lipman AG, Jacox AK, eds. Pain in osteoarthritis, rheumatoid arthritis and juvenile chronic arthritis. 2nd ed. Glenview (IL): American Pain Society (APS), 2002. 179.
  • 6Zhang W, Doherty M, Leeb BF, et al. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis, 2007, 66: 377-388.
  • 7Zhang W, Doherty M. EULAR recommendations for knee and hip osteoarthritis: a critique of the methodology. Br J Sports Med, 2006, 40: 664-669.
  • 8Pendleton A, Arden N, Dougados M, et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis, 2000, 59: 936-944.
  • 9Zhang W, Doherty M, Arden N, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis, 2005, 64: 669-681.
  • 10Chevalier X, Marre JP, de Butler J, et al. Questionnaire survey of management and prescription of general practitioners in knee osteoarthritis: a comparison with 2000 EULAR recommendations. Clin Exp Rheumatol, 2004, 22: 205-212.

共引文献2660

同被引文献8

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部